Sony DADC to Enter Into a Manufacturing Agreement with Trinean

News   Apr 04, 2014

 
Sony DADC to Enter Into a Manufacturing Agreement with Trinean
 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

Optofluidic Device Detects Tumour Cells in Blood

News

A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE